X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2025 Earnings Call Transcript May 1, 2025
X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, expectations were $-4.13.
Operator: Greetings, and welcome to the X4 Pharmaceuticals First Quarter 2025 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference call is being recorded....
